Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance

BACKGROUND: Evidence suggests that interleukin (IL)-1β is important in the pathogenesis of atherosclerosis and its complications and that inhibiting IL-1β may favorably affect vascular disease progression. OBJECTIVES: The goal of this study was to evaluate the effects of IL-1β inhibition with canaki...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudhury, Robin P., Birks, Jacqueline S., Mani, Venkatesh, Biasiolli, Luca, Robson, Matthew D., L’Allier, Philippe L., Gingras, Marc-Alexandre, Alie, Nadia, McLaughlin, Mary Ann, Basson, Craig T., Schecter, Alison D., Svensson, Eric C., Zhang, Yiming, Yates, Denise, Tardif, Jean-Claude, Fayad, Zahi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Biomedical 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064025/
https://www.ncbi.nlm.nih.gov/pubmed/27737744
http://dx.doi.org/10.1016/j.jacc.2016.07.768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064025/
https://www.ncbi.nlm.nih.gov/pubmed/27737744
http://dx.doi.org/10.1016/j.jacc.2016.07.768

Ejemplares similares